DNA-based methods in the immunohematology reference laboratory

Transfusion and Apheresis Science

Volumn 44, Issue 1, 2011, Pages 65-72

  Reid, Marion E ^a   Denomme, Gregory A ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Antibody identification; Blood group antigens; Blood groups; DNA testing; Identification of blood groups; Molecular methods

Indexed keywords

BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; ERYTHROCYTE ANTIGEN; HLA DO ANTIGEN; ALLOANTIBODY; RHESUS ANTIGEN;

ALLELE; ARTICLE; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; DNA DETERMINATION; DNA FINGERPRINTING; FETUS BLOOD SAMPLING; GENETIC DATABASE; GENETIC SCREENING; HEMAGGLUTINATION; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REFERENCE DATABASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SICKLE CELL ANEMIA; ALLOIMMUNIZATION; AMNIOCENTESIS; AMNION CELL; ANTIGEN EXPRESSION; BLOOD GROUP SYSTEM; CHROMOSOME MAP; DONOR; GENE STRUCTURE; HEMATOLOGICAL PARAMETERS; HUMAN GENOME PROJECT; IMMUNOHEMATOLOGY; IMMUNOLOGICAL PARAMETERS; INTRAUTERINE BLOOD TRANSFUSION; LABORATORY TEST; MATERNAL PLASMA; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; PHENOTYPE; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING;

ADULT; ALLERGY AND IMMUNOLOGY; BLOOD BANKS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; DNA; FEMALE; FETAL BLOOD; HEMATOLOGIC DISEASES; HEMATOLOGY; HUMANS; INFANT, NEWBORN; INFORMED CONSENT; LABORATORIES; MOLECULAR DIAGNOSTIC TECHNIQUES; PREGNANCY; PREGNANCY COMPLICATIONS; REFERENCE STANDARDS;

EID: 79951671217     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.12.011     Document Type: Article

References (69)

1. Daniels G., Castilho L., Flegel W.A., Fletcher A., Garratty G., Levene C., et al. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Macao report. Vox Sang 2009, 96:153-156.
2. Storry J.R. New technologies to replace current blood typing reagents. Curr Opin Hematol 2007, 14:677-681.
3. Westhoff C.M. The potential of blood group genotyping for transfusion medicine practice. Immunohematology 2008, 24:190-195.
4. Avent N.D. Large-scale blood group genotyping: clinical implications. Br J Haematol 2009, 144:3-13.
5. Veldhuisen B., van der Schoot C.E., de H.M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009, 97:198-206.
6. Daniels G. The molecular genetics of blood group polymorphism. Human Genetics 2009 Electronic citation ahead of print: PM:19727826.
7. Lögdberg L., Reid M.E., Lamont R.E., Zelinski T. Human blood group genes 2004: chromosomal locations and cloning strategies. Transf Med Rev 2005, 19:45-57.
8. 2 histo-blood groups made possible by identification of a novel A4GALT exon (abstract). Transfusion 2009, 49(Suppl.):48A.
9. Tilley L, Green C, Poole J, Gaskell A, Ridgwell K, Burton NM, et al. A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sanguinis 2009 Electronic citation ahead of print: PM:19744193.
10. Denomme G.A., Flegel W.A. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008, 48:2461-2475.
11. van der Schoot C.E., de H.M., Engelfriet C.P., Reesink H.W., Panzer S., Jungbauer C., et al. Genotyping for red blood cell polymorphisms. Vox Sang 2009, 96:167-179.
12. Hashmi G., Shariff T., Zhang Y., Cristobal J., Chau C., Seul M., et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007, 47:736-747.
13. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., Sayers E.W. GenBank. Nucleic Acids Res 2009, 37:D26-D31.
14. Sayers E.W., Barrett T., Benson D.A., Bryant S.H., Canese K., Chetvernin V., et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2009, 37:D5-15.
15. Blumenfeld O.O., Patnaik S.K. Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the blood group antigen gene mutation database. Hum Mutat 2004, 23:8-16.
16. van Wamelen D.J., Klumper F.J., de H.M., Meerman R.H., van Kamp I.L., Oepkes D. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstet Gynecol 2007, 109:1093-1098.
17. Vaughan J.I., Warwick R., Letsky E., Nicolini U., Rodeck C.H., Fisk N.M. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994, 171:247-252.
18. Seto E., Fernandes B.J., Wang C., Denomme G.A. Predictive blood group genetics in hemolytic disease of the fetus and newborn: a 10-year review of a laboratory evaluation of amniotic fluid-derived DNA. Prenat Diagn 2007, 27:1017-1023.
19. Maddocks D.G., Alberry M.S., Attilakos G., Madgett T.E., Choi K., Soothill P.W., et al. The SAFE project: towards non-invasive prenatal diagnosis. Biochem Soc Trans 2009, 37:460-465.
20. Finning K., Martin P., Summers J., Daniels G. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 2007, 47:2126-2133.
21. Deng Z., Wu G., Li Q., Zhang X., Liang Y., Li D., et al. Noninvasive genotyping of 9 Y-chromosome specific STR loci using circulatory fetal DNA in maternal plasma by multiplex PCR. Prenat Diagn 2006, 26:362-368.
22. Avent N.D., Reid M.E. The Rh blood group system: a review. Blood 2000, 95:375-387.
23. Flegel W.A., von Z.I., Wagner F.F. Six years' experience performing RHD genotyping to confirm D-red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009, 49:465-471.
24. Polin H., Danzer M., Gaszner W., Broda D., St-Louis M., Proll J., et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D-blood donors in Upper Austria. Transfusion 2009, 49:676-681.
25. Okuda H., Kawano M., Iwamoto S., Tanaka M., Seno T., Okubo Y., et al. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 1997, 100:373-379.
26. Sun C.F., Chou C.S., Lai N.C., Wang W.T. RHD gene polymorphisms among RhD-negative Chinese in Taiwan. Vox Sang 1998, 75:52-57.
27. Peng C.T., Shih M.C., Liu T.C., Lin I.L., Jaung S.J., Chang J.G. Molecular basis for the RhD negative phenotype in Chinese. Int J Mol Med 2003, 11:515-521.
28. Richard M., Perreault J., Constanzo-Yanez J., Khalife S., St-Louis M. A new DEL variant caused by exon 8 deletion. Transfusion 2007, 47:852-857.
29. Yang Y.F., Wang Y.H., Chen J.C., Eng H.L., Lin T.M. Prevalence of RHD 1227A and hybrid Rhesus box in the general Chinese population. Trans Res 2007, 149:31-36.
30. Ye L., Yue D., Wo D., Ding X., Guo S., Li Q., et al. Molecular bases of unexpressed RHD alleles in Chinese D-persons. Transfusion 2009.
31. Singleton B.K., Green C.A., Avent N.D., Martin P.G., Smart E., Daka A., et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000, 95:12-18.
32. Pham B.N., Peyrard T., Juszczak G., Dubeaux I., Gien D., Blancher A., et al. Heterogeneous molecular background of the weak C, VS+, hr B-, Hr B- phenotype in black persons. Transfusion 2009, 49:495-504.
33. Daniels G., van der Schoot C.E., Olsson M.L. Report of the second international workshop on molecular blood group genotyping. Vox Sang 2007, 93:83-88.
34. Legler T.J., Eber S.W., Lakomek M., Lynen R., Maas J.H., Pekrun A., et al. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion 1999, 39:852-855.
35. Reid M.E., Rios M., Powell V.I., Charles-Pierre D., Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000, 40:48-53.
36. Wenk R.E., Chiafari P.A. DNA typing of recipient blood after massive transfusion. Transfusion 1997, 37:1108-1110.
37. Brown D.J. A rapid method for harvesting autologous red cells from patients with hemoglobin S disease. Transfusion 1988, 28:21-23.
38. Reid M.E., Lomas-Francis C. Blood Group Antigen FactsBook 2004, Academic Press, San Diego. 2nd ed.
39. Bosco A., Xenocostas A., Kinney J., Cadwell C.M., Zimring J.C. An autoanti-Kp b immunoglobulin M that simulates antigen suppression. Transfusion 2009, 49:750-756.
40. Reid M.E., Yazdanbakhsh K. Molecular insights into blood groups and implications for blood transfusion. Curr Opin Hematol 1998, 5:93-102.
41. Daniels G. The molecular genetics of blood group polymorphism. Hum Genet 2009.
42. Yazdanbakhsh K., Rios M., Storry J.R., Kosower N., Parasol N., Chaudhuri A., et al. Molecular mechanisms that lead to reduced expression of duffy antigens. Transfusion 2000, 40:310-320.
43. Storry J.R., Reid M.E., Fetics S., Huang C.H. Mutations in GYPB exon 5 drive the S-s-U+(var) phenotype in persons of African descent: implications for transfusion. Transfusion 2003, 43:1738-1747.
44. Lucien N., Sidoux-Walter F., Olives B., Moulds J., Le Pennec P.Y., Cartron J.P., et al. Characterization of the gene encoding the human Kidd blood group/urea transporter protein. Evidence for splice site mutations in Jknull individuals. J Biol Chem 1998, 273:12973-12980.
45. Lee M.T., Piomelli S., Granger S., Miller S.T., Harkness S., Brambilla D.J., et al. Stroke prevention trial in sickle cell anemia (STOP): extended follow-up and final results. Blood 2006, 108:847-852.
46. Adams R.J., Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005, 353:2769-2778.
47. Hoeltge G.A., Domen R.E., Rybicki L.A., Schaffer P.A. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159, 262 patients from 1985 to 1993. Arch Pathol Lab Med 1995, 119:42-45.
48. Redman M., Regan F., Contreras M. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 1996, 71:216-220.
49. Rosse W.F., Gallagher D., Kinney T.R., Castro O., Dosik H., Moohr J., et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990, 76:1431-1437.
50. Aygun B., Padmanabhan S., Paley C., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002, 42:37-43.
51. McPherson ME, Anderson AR, Castillejo MI, Hillyer CD, Bray RA, Gebel HM, et al. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 2009 Electronic citation ahead of print: PM:19890898.
52. Storry J.R., Olsson M.L., Reid M.E. Application of DNA analysis to the quality assurance of reagent red blood cells. Transfusion 2007, 47(Suppl.):73S-78S.
53. Hashmi G., Shariff T., Seul M., Vissavajjhala P., Hue-Roye K., Charles-Pierre D., et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005, 45:680-688.
54. Denomme G.A., Van O.M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005, 45:660-666.
55. Palacajornsuk P., Halter C., Isakova V., Tarnawski M., Farmar J., Reid M.E., et al. Detection of blood group genes using multiplex SNaPshot method. Transfusion 2009, 49:740-749.
56. Hopp K, Weber K, Bellissimo D, Johnson ST, Pietz B. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2009 Electronic citation ahead of print: PM:19761548.
57. Reid M.E. The Dombrock blood group system: a review. Transfusion 2003, 43:107-114.
58. Wagner F.F., Ladewig B., Flegel W.A. The RHCE allele ceRT: D epitope 6 expression does not require D-specific amino acids. Transfusion 2003, 43:1248-1254.
59. Flegel W.A., Wagner F.F., Chen Q., Schlanser G., Frame T., Westhoff C.M., et al. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion 2006, 46:1334-1342.
60. Chen Q., Hustinx H., Flegel W.A. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion 2006, 46:766-772.
61. Yazdanbakhsh K., Oyen R., Yu Q., Lee S., Antoniou M., Chaudhuri A., et al. High-level, stable expression of blood group antigens in a heterologous system. Am J Hematol 2000, 63:114-124.
62. Tilley L., Green C., Poole J., Gaskell A., Ridgwell K., Burton N.M., et al. A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang 2009.
63. Avent N.D., Liu W., Scott M.L., Jones J.W., Voak D. Site directed mutagenesis of the human Rh D antigen: molecular basis of D epitopes. Vox Sang 2000, 78(Suppl. 2):83-89.
64. Seltsam A., Blasczyk R. Recombinant blood group proteins for use in antibody screening and identification tests. Curr Opin Hematol 2009, 16:473-479.
65. Halverson G.R., Tossas E., Velliquette R.W., Lobo C., Reid M.E., Frame T., et al. Murine monoclonal anti-s and other anti-glycophorin B antibodies resulting from immunizations with a GPB.s peptide. Transfusion 2009, 49:485-494.
66. Tearina Chu T.H., Halverson G.R., Yazdanbakhsh K., Oyen R., Reid M.E. A DNA-based immunization protocol to produce monoclonal antibodies to blood group antigens. Br J Haematol 2001, 113:32-36.
67. Gassner C., Rozman P. RHD DNA screening for weak D, DEL and D+/- 'chimeras'. Vox Sang 2006, 91:184.
68. Helming A.M., Brand A., Wolterbeek R., van Tol M.J., Egeler R.M., Ball L.M. ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr Blood Cancer 2007, 49:313-317.
69. Chapel-Fernandes S., Callebaut I., Halverson G.R., Reid M.E., Bailly P., Chiaroni J. Dombrock genotyping in a native Congolese cohort reveals two novel alleles. Transfusion 2009.